Radiographic features
Ultrasound
Scoring is determined from five categories of ultrasound findings (figure 2). The higher the cumulative score, the higher the TR (TI-RADS) level and the likelihood of malignancy.
One score is assigned from each of the following categories:
- composition: (choose one)
- cystic or completely cystic *: 0 points
- spongiform *: 0 points
- mixed cystic and solid: 1 point
- solid or almost completely solid: 2 points
- echogenicity: (choose one)
- anechoic: 0 points
- hyper- or isoechoic: 1 point
- hypoechoic: 2 points
- very hypoechoic: 3 points
- shape: (choose one) (assessed on the transverse plane)
- wider than tall: 0 points
- taller than wide: 3 points
- margin: (choose one)
- smooth: 0 points
- ill-defined: 0 points
- lobulated/irregular: 2 points
- extra-thyroidal extension: 3 points
Any and all findings in the final category are also added to the other four scores.
- echogenic foci: (choose one or more)
- none: 0 points
- large comet-tail artifact: 0 points
- macrocalcifications: 1 point
- peripheral/rim calcifications: 2 points
- punctate echogenic foci: 3 points
The findings in each category were detailed in the ACR committee’s 2015 publication on a reporting lexicon 2. If multiple nodules are present only the four highest-scoring nodules (not necessarily the largest) should be scored, reported, and followed up.
* Predominantly cystic or spongiform nodules are inherently benign. If these features are present no further points will be added (automatically TR1).
Classification
- TR1: 0 points
- benign
- TR2: 2 points
- not suspicious
- TR3: 3 points
- mildly suspicious
- TR4: 4-6 points
- moderately suspicious
- TR5: ≥7 points
- highly suspicious
Recommendations
- TR1: no FNA required
- TR2: no FNA required
- TR3: ≥1.5 cm follow up, ≥2.5 cm FNA
- follow up: 1, 3 and 5 years
- TR4: ≥1.0 cm follow up, ≥1.5 cm FNA
- follow up: 1, 2, 3 and 5 years
- TR5: ≥0.5 cm follow up, ≥1.0 cm FNA
- annual follow up for up to 5 years
Radiographic features
Ultrasound
Scoring is determined from five categories of ultrasound findings (figure 2). The higher the cumulative score, the higher the TR (TI-RADS) level and the likelihood of malignancy.
One score is assigned from each of the following categories:
- composition: (choose one)
- cystic or completely cystic *: 0 points
- spongiform *: 0 points
- mixed cystic and solid: 1 point
- solid or almost completely solid: 2 points
- echogenicity: (choose one)
- anechoic: 0 points
- hyper- or isoechoic: 1 point
- hypoechoic: 2 points
- very hypoechoic: 3 points
- shape: (choose one) (assessed on the transverse plane)
- wider than tall: 0 points
- taller than wide: 3 points
- margin: (choose one)
- smooth: 0 points
- ill-defined: 0 points
- lobulated/irregular: 2 points
- extra-thyroidal extension: 3 points
Any and all findings in the final category are also added to the other four scores.
- echogenic foci: (choose one or more)
- none: 0 points
- large comet-tail artifact: 0 points
- macrocalcifications: 1 point
- peripheral/rim calcifications: 2 points
- punctate echogenic foci: 3 points
The findings in each category were detailed in the ACR committee’s 2015 publication on a reporting lexicon 2. If multiple nodules are present only the four highest-scoring nodules (not necessarily the largest) should be scored, reported, and followed up.
* Predominantly cystic or spongiform nodules are inherently benign. If these features are present no further points will be added (automatically TR1).
Classification
- TR1: 0 points
- benign
- TR2: 2 points
- not suspicious
- TR3: 3 points
- mildly suspicious
- TR4: 4-6 points
- moderately suspicious
- TR5: ≥7 points
- highly suspicious
Recommendations
- TR1: no FNA required
- TR2: no FNA required
- TR3: ≥1.5 cm follow up, ≥2.5 cm FNA
- follow up: 1, 3 and 5 years
- TR4: ≥1.0 cm follow up, ≥1.5 cm FNA
- follow up: 1, 2, 3 and 5 years
- TR5: ≥0.5 cm follow up, ≥1.0 cm FNA
- annual follow up for up to 5 years